Experts see boost to genetic testing from US bill

As a clinician leader for some time, it is overtly obvious that comprehensive genetic testing will be fraught with misinterpretation and will lead to consumer confusion and potentially wrong life behavior. Genetic testing has been available for 2-3 decades on a very limited basis and for specific fetal diseases yet physicians wholly inadequately trained are referring patients to nursing geneticists...

The Genetic Information Nondiscrimination Act (GINA), which will soon become law, will protect Americans who choose to have genetic testing against the fear of discrimination by employers and health insurers. The idea of personalized medicine can not become a reality with out the passage of GINA.

There are many reasons why the commercialization of human genome "information" will be ABSOLUTE CHAOS AND COST.  The three most prominent are the following:   1. Physician education is almost devoid of practical genomic teachings except for Diabetes and lipid disorders.   2.  Fully 85% of genetic referrals now are inappropriate with "simple" genetics.  Human genomic knowledge...

The passage of this bill by the Senate and the likely passage by the house are both good for consumers as well as the companies that conduct genetic testing.